Objective. Chronic pain management is a growing focus of attention, in part because of concern over excessive use of opioids for treatment of chronic noncancer pain. In the Veterans Health Administration (VHA), pain specialty clinics have been established to address the needs of patients with challenging pain issues. The current study identified characteristics of such patients in a national sample of VHA service users in fiscal year 2012.
Introduction
In the United States, there is a striking prevalence of chronic pain [1, 2] . These growing rates are of particular relevance to the aging United States Veteran population, and especially service users of the Veterans Health Administration (VHA). Such users are often diagnosed with chronic pain, frequently of musculoskeletal origin. In many cases, this chronic pain results from physical injuries acquired during their military service [3] . Accordingly, there has been growing attention to the management of chronic pain; mirroring the goal of the VHA [4] , in 2000 the United States Joint Commission on Accreditation of Health Care Organizations corroborated that pain be considered "the fifth vital sign" [5] . It has also been noted that chronic pain is often further complicated by comorbid psychiatric disorders including anxiety, depression, PTSD, and substance abuse [6, 7] .
Although opioids are a cornerstone in the treatment of acute pain, their long-term efficacy and safety for the treatment of chronic pain has been widely questioned, and a high prevalence of prescription opioid addiction has resulted from extensive and perhaps excessive therapeutic use of these medications [8] . In addition, several psychotropic medications are used for the treatment of pain [9] . For example, some antidepressants (e.g., duloxetine) are often used to treat musculoskeletal pain [10] , while atypical antipsychotics have shown mixed results in the treatment of fibromyalgia [11, 12] and acute and chronic pain [13] . Further, anticonvulsants and tricyclic antidepressants have been used to treat neuropathic pain [14] .
Pain remains one of the most frequent reasons for high levels of health service utilization, resulting in costs upwards of $500 billion per year [1, 2, 7] . As such, understanding the sociodemographic and diagnostic characteristics of chronic pain patients along with patterns of service use and psychotropic medication prescription fills, especially among those presenting the most difficult-to-treat pain problems, is important to identifying the distinctive needs of these patients, as well as safe and efficacious treatment paradigms.
The VHA has developed multidisciplinary pain specialty clinics [15] . These clinics are composed of physicians encompassing physical medicine and rehabilitation, primary care, anesthesiology, neurology, and mental health expertise, including health psychologists. Further, pain clinics often include specialists in complementary and alternative therapies. The goal of such clinics is to achieve optimal pain relief through a combination of both pharmacological and nonpharmacological modalities, while also addressing other factors accompanying and/or exacerbating chronic pain diagnoses. Recently, one study suggested that superior patient and clinician satisfaction is associated with treatment in such specialized settings [16] .
Several previous studies have examined the efficacy of multidisciplinary pain clinics [17, 18] , psychosocial correlates, and costs of their utilization in heterogeneous populations [19, 20] . These studies suggest that patients utilizing pain specialty clinics are more likely to have more severe pain and impairment in functioning, poorer psychosocial adjustment, and higher levels of overall health care utilization [19, 20] . However, to our knowledge, no studies have examined these factors in national health care systems such as the VHA. Thus, the current study sought to identify sociodemographic and clinical characteristics of patients who received a pain diagnosis and whose pain is being addressed in a pain specialty clinic, as compared with those who did not receive such specialized treatment. We compare sociodemographic characteristics, medical and psychiatric diagnoses, health service use, and, especially, psychotropic and opioid drug use among veterans who attended a pain clinic in 2012, as compared with those who did not.
Methods

Sample, Sources of Data
The sample included in the current analysis consisted of 2,075,765 veterans who received a pain diagnosis (based on ICD-9 codes presented below) in fiscal year 2012 (October 1, 2011, to September 30, 2012). Altogether, 120,240 (5.79%) patients diagnosed with pain visited a pain clinic (identified by primary or secondary use of stop code 420) at least once during the fiscal year, while 1,955,525 (94.21%) did not. Data on sociodemographic characteristics, diagnoses (pain, medical, and psychiatric), and treatment (mental health and medical-surgical service use) were obtained from outpatient encounter files and the patient treatment files, while data on medications (opioids, psychotropic medications) were retrieved from the Department of Veterans Affairs (VA) Drug Benefit Management database. Diagnoses were based on the International Classification of Diseases, 9th edition (ICD-9).
Measures
Sociodemographics
Sociodemographic data included age, gender, rural/urban residence (urban, small rural, large rural, isolated rural) derived from Rural-Urban Commuting Area codes (Morrill et al. 1999), Operation Enduring Freedom/ Operation Iraqi Freedom (OEF/OIF) veteran status, VA compensation or pension status including service connection status (classified by disability ratings of ! 50% or < 50%), and homelessness status (documented by use of a specialized homeless service program encounter codes or a V60 ICD-9 code).
Medical Diagnoses
Data on medical diagnoses (based on ICD-9 codes) included metastatic cancer, paraplegia, liver disease, headaches, connective tissue disease, insomnia, HIV, seizure disorder, peptic ulcer disease, chronic pulmonary disease, diabetes mellitus, peripheral vascular disease, congestive heart failure, and myocardial infarction-all component diagnoses of the Charlson Comorbidity Index (Charlson et al. 1987) , which was originally developed to predict mortality risk and was used here to assess the severity of medical comorbidity. These were included in the analysis in order to Pain Clinic Use in the VHA determine if those attending a pain clinic were more likely to present with corresponding medical conditions.
Psychiatric Diagnoses
Psychiatric diagnoses, based on ICD-9 codes (available on request) were classified as follows: any psychiatric disorder, any substance abuse diagnosis, drug dependence, alcohol dependence, dual diagnosis, major depression, other depression (e.g., dysthymia), bipolar disorder, any anxiety disorder, post-traumatic stress disorder, adjustment disorder, personality disorder, schizophrenia, organic brain syndrome, other psychiatric diagnosis, and any mental health diagnosis.
Pain Diagnoses
Twenty-eight ICD-9 diagnostic codes for pain were clustered into seven variables that were included for analysis. The seven variables and their corresponding ICD-9 codes were as follows : 1) 
Psychotropic Medications
Psychotropic medications were categorized according to eight classes: 1) antidepressants, 2) antipsychotics, 3) anticonvulsants/mood stabilizers, 4) anxiolytics/sedatives/hypnotics, 5) stimulants, 6) lithium, 7) opioids, and 8) any psychotropics. Specific agents included in each class are available from the first author upon request.
Service Use
Service use, or the number of outpatient mental health visits, as well as medical-surgical and emergency department visits by each veteran, was calculated from encounter form data classified by clinic stop codes. Use of any inpatient mental health care, based on discharge abstracts from the patient treatment file, was represented by a single dichotomous variable (yes/no).
Data Analysis
We first conducted bivariate comparisons of veterans with pain diagnoses who attended a pain clinic and who did not in fiscal year 2012 on: 1) sociodemographic characteristics, 2) general medical diagnoses, 3) pain diagnoses, 4) psychiatric diagnoses, 5) psychotropic medications, and 6) service use. Subsequently, we performed stepwise logistic regression analyses to identify factors that were independently associated with pain clinic attendance in this sample. Standardized regression coefficients were included in the model output to allow comparison of effect sizes between dichotomous and continuous variables.
As sample size is reflected in P values, there is an inflated risk of significant P values in larger samples such as that currently under study (N ¼ 2,075,765). Therefore in bivariate analyses, we utilized risk ratios for comparison of categorical variables (e.g., prevalence of medical and psychiatric diagnoses) and Cohen's d (difference in means divided by the pooled standard deviation [21] ) for those involving continuous variables (i.e., service use, number of psychotropic medication fills). Risk ratios > 1.5 or < 0.5 and Cohen's d values > 0.2 were considered to indicate substantial differences of clinical importance and were included in the subsequent logistic regression analysis.
Results
Sample
Participants included 2,075,765 veterans who had a pain diagnosis in fiscal year 2012. Within this group, 120,240 (5.79%) attended a pain clinic at least once (with an average number of pain clinic visits ¼ 3.14, SD ¼ 3.59), while 1,955,525 (94.21%) did not. The average age of all participants was 57.12 years, and the sample was predominately male (90.27%). In this largely white sample (76.4%), most were urban residents (71.7%).
Bivariate Analysis of Those with a Pain Diagnosis
There were no sociodemographic characteristics that were substantially different, by the above criteria, between veterans attending a pain clinic and those who did not (Table 1) . With regard to psychiatric diagnoses, veterans who attended a pain clinic were at least one and a half times more likely to be diagnosed with drug dependence, PTSD, bipolar disorder, or an anxiety or adjustment disorder. Further, the pain clinic cohort was more than twice as likely to be diagnosed with major depression or a personality disorder (Table 2) .
While joint pain, generalized pain, and central pain syndrome were the most common and similarly prevalent pain diagnosis categories among both groups (59.4% vs 51% for those visiting a pain clinic vs others), fibromyalgia, neuralgia, neuritis, and radiculitis diagnoses were those with the largest differences in frequency between groups. Specifically, those who visited a pain clinic were over three and a half times more likely to have diagnoses within this category when compared with those who did not ( Table 2 ).
The mean number of opioid prescriptions received was also substantially greater among those treated in a pain clinic and was the only notable medication difference approaching a moderate effect size (d ¼ 0.45). However, prescriptions for antidepressants, anxiolyticsedative hypnotics, anticonvulsants-mood stabilizers, and all nonopioid psychotropics taken together exceeded the 0.20 d standard for at least a small effect representing greater psychotropic use among veterans who used pain clinic services (Table 3) .
Notably, while the groups utilized psychiatric or substance abuse outpatient services at similar levels, use of medicalsurgical outpatient visits was substantially greater among veterans attending pain clinics (d ¼ 0.64) ( Table 4) .
Multivariate Analysis of Pain Clinic Attendance
Among veterans with a pain diagnosis, the strongest independent predictor of pain clinic attendance in 2012 was receipt of opioid prescriptions (see standardized regression coefficient [SRC] of 0.19 in Table 5 ). Further, medical surgical service utilization (SRC ¼ 0.16) and the diagnoses of fibromyalgia, neuralgia, neuritis, and radiculitis (SRCs of 0.13 and 0.07, respectively), along with major depressive disorder (SRC ¼ 0.05), were notable independent correlates of attending a specialized pain clinic ( Table 5 ). Use of antidepressants and anxiolytics was also associated with pain clinic attendance.
Because of the substantially greater pain clinic use among patients with drug use disorders and affective disorders, we further evaluated the interaction of mental health clinic use and these mental health diagnoses to see if users of pain clinic services with these diagnoses were more or less likely to also use specialized mental health services. A negative interaction was observed between a diagnosis of drug dependence and use of mental health services, such that patients with drug abuse/dependence diagnoses were less likely to be seen in a mental health clinic if they were also seen in a pain clinic. In contrast, those diagnosed with depression were slightly more likely to receive treatment from a mental health clinic if they were also seen in a pain clinic (Table 5) .
Discussion
In the current study, several notable correlates of pain clinic attendance emerged. First, patients with particular types of pain conditions were more likely to receive treatment in VHA pain clinics than others. Specifically, it appears that more debilitating or difficult-to-treat pain conditions such as fibromyalgia, neuralgia, neuritis, and radiculitis lead providers to refer and/or patients to seek specialized pain treatment. Secondly, the data indicate that associations with these pain diagnoses appear to be independent of specific major medical diagnoses. Particularly notable was the modest association of cancer diagnoses and treatment in pain specialty clinics, with a prevalence of approximately 9% among both users and nonusers of such services. Cancer pain is multifaceted in nature and thus complicated, arising from tumors, chemotherapy, radiation, or related surgeries. There are many available guidelines for the treatment of such pain [22, 23] , although more than 40% of patients with cancer pain are reported to be inadequately treated [24, 25] . Nonetheless, our results suggest that those with cancer pain are not often referred to pain specialty clinics, with one possible explanation being that those with cancer pain may be referred to palliative care [26] , rather than the former. Altogether, these findings are consistent with our belief that ambiguous pain states with contributory psychiatric factors most often require specialized treatment, and these are the circumstances leading to pain clinic utilization.
Third, consistent with the notion that diagnostic ambiguity drives pain specialty clinic use is that fibromyalgia, an elusive chronic pain condition characterized by widespread pain and diffuse tenderness [27] , is an especially strong correlate of pain clinic use. While the most prominent sociodemographic correlate of fibromyalgia has been reported to be female gender [28] , it was nevertheless the pain diagnosis most strongly associated with pain clinic attendance in VHA, even though the current sample was 90% male. While we speculate that the high incidence of fibromyalgia in this sample is secondary to diagnostic ambiguity, it should be noted that it might also reflect the severe nature of the pain and subsequent functional impairment, as well as poor responsiveness to standard therapy. There is no unanimously supported etiology or treatment for fibromyalgia, and pharmacological treatment with antidepressants [29] or anticonvulsants [30] in combination with physical therapy is the most widely used approach [27] , although the benefits of this regime are not well demonstrated [31] . This diagnosis is also thought to have a substantial psychiatric comorbidity [32] , consistent with the high rate of patients with psychiatric diagnoses who are referred for pain clinic services. The increased use of antidepressants and anticonvulsants in pain clinic users may reflect, at least in part, treatment of fibromyalgia; in fact, pregabalin is US Food and Drug Administration-approved to treat fibromyalgia.
A fourth notable finding is that patients attending pain specialty clinics received substantially higher numbers of opioid prescriptions, on average, than other patients with pain diagnoses. Though this may reflect the more severe and treatment-resistant pain conditions that spur referral to these clinics, it may also reflect the concern of referring physicians for patients who have not responded well to opioid treatments, leading to a referral to pain specialty clinics. Specifically, primary care physicians may refer patients to pain specialty clinics due to concern over high doses of opioids. These clinics may assist the patient in titrating down or discontinuing the opioids in pursuit of a safer treatment paradigm using other nonopioid medications or alternative nonpharmacologic therapies. In the current study, a substantial association was observed between pain clinic use and drug addiction diagnoses, suggesting that referring providers are likely to be concerned about the risk of addiction as well as hyperalgesia, in which pain worsens with more extensive opioid use. Multimodal treatment that includes a mental health component is increasingly suggested as the desired approach to the management of chronic pain [33] .
It is also notable that veterans diagnosed with drug dependence were less likely to seek specialized treatment for pain if they utilized mental health services. This may suggest that mental health clinics are able to address both substance abuse and pain among those who are willing to seek mental health treatment from drug use problems. Further, patients with comorbid pain and drug abuse who do not seek mental health treatment may be especially challenging for their primary care physicians, who consequently refer them to pain specialty clinics, perhaps because they refuse direct treatment for drug abuse. In contrast, patients diagnosed with comorbid depression and pain and who use mental health services were slightly more likely to be seen in pain clinics than other depressed pain patients, suggesting that these patients willingly seek treatment for their depression, but that their mental health providers seek specialized treatment for their concomitant pain.
While the VHA systematically promotes the multidisciplinary treatment of chronic pain that encompasses expertise from multiple aforementioned specialties [34] , the current data further highlight the need for a strong mental health component in these treatment programs. This need is underscored by each of our main findings: 1) difficult-to-treat and particularly debilitating pain conditions with historically robust psychiatric components were most predictive of pain clinic attendance, and these patients are more likely to utilize medical rather than mental health services; 2) psychiatric rather than medical comorbidity appears to be robustly associated with pain clinic attendance; and 3) pain patients referred to pain specialty clinics tend to receive more opioids, possibly indicating concern about the management of potentially addictive treatments with psychiatric comorbidities in primary care. The data presented here thus demonstrate in several ways the prominence of distinctive behavioral health challenges in the specialized treatment of clinically difficult pain patients referred to pain specialty clinics. Previous studies have also suggested that people utilizing pain specialty clinics were more psychologically vulnerable and had poor social support when compared with other patients [19, 20] . Altogether, these findings clearly encourage the inclusion or close coordination of mental health care in the treatment of chronic pain and call for further study of the behavioral service needs of this population.
Several limitations of this study require comment. First, although the VHA does collect pain severity ratings, these ratings were not included in the data set to which we had access. While we have information on the types of pain conditions associated with attendance at pain specialty clinics, we did not have information on the severity of pain, which may have been informative. Specifically, we may have been better able to determine what drives pain clinic attendance had we been able to assess if patients with more severe pain are more likely to be referred to these clinics when compared with those with less severe pain ratings. However, the special role of behavioral health problems in the care of these patients, the primary finding of our study, is not likely to have been affected by access to these additional pain severity data. Secondly, we were unable to determine whether the high rate of opioid prescriptions fueled clinician referrals to pain specialty clinics, or if the pain clinics were themselves prescribing opioids. While we believe the former to be the more likely interpretation, this is only speculation as specific dates for pain clinic referrals were unavailable for analysis. Finally, detailed information on the specific behavioral health services provided by pain clinics at different VA medical centers is not available. The lack of such data precludes more specific description of the variability in both the extent to which behavioral health issues are addressed in pain clinics and the approaches used to provide such services across VHA facilities.
Despite these limitations, this is the first study to our knowledge that provides information on the proportion and characteristics of pain sufferers who use pain specialty clinic services in a national health care system, the VHA, and it clearly highlights the behavioral health needs of these patients.
